BAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office

Stock News11-27

BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the "Tonghe Area Land Reserve Implementation Plan." On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.

According to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the "clean land" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160975531?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-27 19:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160975531","market":"fut","top_or_hot":-1,"title":"BAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office","media":"Stock News","content":"<p>BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the \"Tonghe Area Land Reserve Implementation Plan.\" On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.</p>\n<p>According to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the \"clean land\" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-27 19:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the \"Tonghe Area Land Reserve Implementation Plan.\" On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.</p>\n<p>According to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the \"clean land\" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01477","symbol_name":"欧康维视生物-B","start_time":0,"source_url":"","article_id":"1160975531","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160975531","pubTimestamp":1764242442,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600332":"白云山","01477":"欧康维视生物-B","BK1191":"制药","BK0175":"白马股","BK1515":"抗疫概念","BK0070":"员工持股","BK1574":"生物医药B类股","BK1606":"中医药概念","BK0196":"行业龙头","BK0097":"医药电商","BK1197":"保健护理产品经销商","BK0239":"医药制造","00874":"白云山","BK0096":"民营医院","BK1521":"挪威政府全球养老基金持仓","BK0183":"MSCI概念","BK0188":"融资融券","BK0012":"证金概念","BK0028":"国家队"},"translate_title":"白云山PH(00874)：光华药业与同和街道办事处签订土地储备补偿协议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600332":1,"00874":1,"01477":1},"content_text":"BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the \"Tonghe Area Land Reserve Implementation Plan.\" On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.\nAccording to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the \"clean land\" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160975531","isCrawlerRequest":true}